World

UN chief 'alarmed' about worsening food security in Sudan

Dec 25, 2024

New York [US], December 25: UN Secretary-General Antonio Guterres on Tuesday expressed concern about the escalating food insecurity in Sudan, warning of famine conditions in several areas amid the conflict.
"The Secretary-General is alarmed by the rapidly worsening food security situation in Sudan, as access to food and nutrition for millions of people across the country continues to deteriorate according to the Integrated Food Security Phase Classification (IPC)," spokesperson Stephanie Tremblay said in a statement.
Saying that the "latest report by the IPC's Famine Review Committee indicates that famine conditions are present in at least five locations in Sudan," the statement indicated displacement camps in North Darfur and the western Nuba Mountains in South Kordofan as areas of risk.
Additionally, five other areas are deemed at risk of famine in the coming months, according to the IPC.
Stressing that "more than 24.6 million people in Sudan-over half the population-face high levels of acute food insecurity" with the conflict, the statement further noted that "ongoing fighting and restrictions on the movement of relief supplies and personnel continue to imperil aid operations."
Guterres renewed "his call for the parties to facilitate rapid, safe, unhindered and sustained access so that humanitarian assistance and staff can reach people in need wherever they are."
Source: Emirates News Agency

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025